ASH 2023 Highlights: POD24 in mantle cell lymphoma (MCL)



Dr Ali Rismani consultant haematologist from Whittington Hospital, London, Dr Moya Young, consultant haematologist from East Kent Hospital and Dr Lucy Cook, consultant haematologist at Hammersmith Hospital, London discuss the possibility of Progression of Disease in 24 months (POD24) as a prognostic indicator in Mantle Cell Lymphoma and evaluate the key data presented in this space from the meeting.

 

 

Only to be shared with relevant UK haematology healthcare professionals.

CPD® Accreditation

To support your continued professional development the resources hosted in the Resources hub have been certified for CPD® accreditation by the CPD® Certification Service.

Please complete the Request CPD® Certificate form to request a CPD® accredited certificate.